Arcutis Biotherapeutics Inc (ARQT)
14.45 x 2 15.28 x 3
Post-market by (Cboe BZX)
14.62 -0.19 (-1.28%) 03/14/25 [NASDAQ]
14.45 x 2 15.28 x 3
Post-market 14.65 +0.03 (+0.21%) 17:30 ET
for Fri, Mar 14th, 2025
Fiscal Year End Date: 12/31
09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
Sales | 38,109 | 5,190 | 2,781 | 2,961 | 725 |
Cost of Goods | 1,182 | 776 | 783 | 485 | 269 |
Gross Profit | 36,927 | 4,414 | 1,998 | 2,476 | 456 |
Operating Expenses | 74,013 | 71,953 | 79,046 | 71,385 | 105,473 |
Operating Income | -36,904 | -66,763 | -76,265 | -68,424 | -104,748 |
Interest Expense | 7,559 | 7,349 | 7,042 | 6,915 | 4,899 |
Other Income | 2,721 | 3,121 | 3,207 | 3,320 | 1,938 |
Pre-tax Income | -41,742 | -70,991 | -80,100 | -72,019 | -107,709 |
Income Tax | 3,023 | N/A | N/A | N/A | N/A |
Net Income Continuous | -44,765 | -70,991 | -80,100 | -72,019 | -107,709 |
Net Income | $-44,765 | $-70,991 | $-80,100 | $-72,019 | $-107,709 |
EPS Basic Total Ops | -0.73 | -1.16 | -1.31 | -1.19 | -1.89 |
EPS Basic Continuous Ops | -0.73 | -1.16 | -1.31 | -1.19 | -1.89 |
EPS Diluted Total Ops | -0.73 | -1.16 | -1.31 | -1.19 | -1.89 |
EPS Diluted Continuous Ops | -0.73 | -1.16 | -1.31 | -1.19 | -1.89 |
EPS Diluted Before Non-Recurring Items | -0.73 | -1.16 | -1.31 | N/A | N/A |
EBITDA(a) | $-38,049 | $-68,201 | $-78,063 | $-70,419 | $-105,267 |